194 related articles for article (PubMed ID: 35370009)
21. DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
Klinkebiel D; Zhang W; Akers SN; Odunsi K; Karpf AR
Mol Cancer Res; 2016 Sep; 14(9):787-94. PubMed ID: 27259716
[TBL] [Abstract][Full Text] [Related]
22. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
23. KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data.
Zhu S; Bao H; Zhang MC; Liu H; Wang Y; Lin C; Zhao X; Liu SL
BMC Cancer; 2022 Jun; 22(1):662. PubMed ID: 35710397
[TBL] [Abstract][Full Text] [Related]
24. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
Zhang L; Luo M; Yang H; Zhu S; Cheng X; Qing C
J Ovarian Res; 2019 Feb; 12(1):19. PubMed ID: 30786925
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of differential plasma proteins levels in epithelial ovarian cancer.
Periyasamy A; Gopisetty G; Subramanium MJ; Velusamy S; Rajkumar T
J Proteomics; 2020 Aug; 226():103893. PubMed ID: 32634479
[TBL] [Abstract][Full Text] [Related]
26. Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer.
Bahado-Singh RO; Ibrahim A; Al-Wahab Z; Aydas B; Radhakrishna U; Yilmaz A; Vishweswaraiah S
Sci Rep; 2022 Nov; 12(1):18625. PubMed ID: 36329159
[TBL] [Abstract][Full Text] [Related]
27. DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma.
Yang JD; Ghoz H; Aboelsoud MM; Taylor WR; Yab TC; Berger CK; Cao X; Foote PH; Giama NH; Barr Fritcher EG; Mahoney DW; Moser CD; Smyrk TC; Kipp BR; Gores GJ; Roberts LR; Kisiel JB
Hepatol Commun; 2021 Aug; 5(8):1448-1459. PubMed ID: 34430788
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
Li YW; Li L
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
[No Abstract] [Full Text] [Related]
29. Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1.
Maldonado L; Brait M; Izumchenko E; Begum S; Chatterjee A; Sen T; Loyo M; Barbosa A; Poeta ML; Makarev E; Zhavoronkov A; Fazio VM; Angioli R; Rabitti C; Ongenaert M; Van Criekinge W; Noordhuis MG; de Graeff P; Wisman GBA; van der Zee AGJ; Hoque MO
Cancer Lett; 2018 Oct; 433():242-251. PubMed ID: 29964205
[TBL] [Abstract][Full Text] [Related]
30.
Valle BL; Rodriguez-Torres S; Kuhn E; Díaz-Montes T; Parrilla-Castellar E; Lawson FP; Folawiyo O; Ili-Gangas C; Brebi-Mieville P; Eshleman JR; Herman J; Shih IM; Sidransky D; Guerrero-Preston R
Cancer Prev Res (Phila); 2020 Sep; 13(9):783-794. PubMed ID: 32581010
[TBL] [Abstract][Full Text] [Related]
31. DNA Methylation in Ovarian Tumors-a Comparison Between Fresh Tissue and FFPE Samples.
Oliveira DVNP; Hentze J; O'Rourke CJ; Andersen JB; Høgdall C; Høgdall EV
Reprod Sci; 2021 Nov; 28(11):3212-3218. PubMed ID: 33891290
[TBL] [Abstract][Full Text] [Related]
32. Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.
Bondurant AE; Huang Z; Whitaker RS; Simel LR; Berchuck A; Murphy SK
Gynecol Oncol; 2011 Dec; 123(3):581-7. PubMed ID: 21955482
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation signatures and coagulation factors in the peripheral blood leucocytes of epithelial ovarian cancer.
Li L; Zheng H; Huang Y; Huang C; Zhang S; Tian J; Li P; Sood AK; Zhang W; Chen K
Carcinogenesis; 2017 Aug; 38(8):797-805. PubMed ID: 28637314
[TBL] [Abstract][Full Text] [Related]
34. Blood-based DNA methylation profiling for the detection of ovarian cancer.
Li N; Zhu X; Nian W; Li Y; Sun Y; Yuan G; Zhang Z; Yang W; Xu J; Lizaso A; Li B; Zhang Z; Wu L; Zhang Y
Gynecol Oncol; 2022 Nov; 167(2):295-305. PubMed ID: 36096974
[TBL] [Abstract][Full Text] [Related]
35. Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.
Ning L; Lang J; Wu L
BMC Cancer; 2022 Jan; 22(1):6. PubMed ID: 34980005
[TBL] [Abstract][Full Text] [Related]
36. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus.
Iyer PG; Taylor WR; Johnson ML; Lansing RL; Maixner KA; Yab TC; Simonson JA; Devens ME; Slettedahl SW; Mahoney DW; Berger CK; Foote PH; Smyrk TC; Wang KK; Wolfsen HC; Ahlquist DA
Am J Gastroenterol; 2018 Aug; 113(8):1156-1166. PubMed ID: 29891853
[TBL] [Abstract][Full Text] [Related]
37. RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
Häfner N; Steinbach D; Jansen L; Diebolder H; Dürst M; Runnebaum IB
Int J Cancer; 2016 Jan; 138(1):217-28. PubMed ID: 26175272
[TBL] [Abstract][Full Text] [Related]
38. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
39. Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer.
Rusan M; Andersen RF; Jakobsen A; Steffensen KD
Eur J Cancer; 2020 Jan; 125():121-129. PubMed ID: 31865042
[TBL] [Abstract][Full Text] [Related]
40. Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma.
Baranova I; Kovarikova H; Laco J; Sedlakova I; Vrbacky F; Kovarik D; Hejna P; Palicka V; Chmelarova M
Clin Chem Lab Med; 2020 Jul; 58(8):1332-1340. PubMed ID: 32145055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]